Navigation Links
Cancer treatment may result in bone loss
Date:11/13/2008

This press release is available in French.

Montreal, November 13, 2008 A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. In the online edition of the Journal of Clinical Oncology, the scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year* and place them at increased risk for osteoporosis and fractures.

"Our study also looked at possible medications that can reverse or halt bone loss," says Dr. Fred Saad, lead author and director of urologic oncology at the Universit de Montral's Faculty of Medicine and the Centre Hospitalier de l'Universit de Montral (CHUM), who completed the exhaustive study with colleagues from McMaster University, the Universit Laval, the University of Toronto and the University of British Columbia.

"Bone is a dynamic tissue which undergoes a cyclic process of breaking down and rebuilding," adds Dr. Saad. "Medications called bisphosphonates help with the rebuilding process and have been successfully used to combat osteoporosis, which is good news for cancer patients."

Evaluating the studies

Dr. Saad and colleagues evaluated data from more than 3,500 breast and prostate cancer studies. They concluded that breast cancer patients treated with aromatase inhibitors were more likely to have bone loss and fractures compared to patients who didn't receive the therapy. Similarly, men who received androgen deprivation therapy to treat their prostate cancer had an increased risk of bone disorders. Although the numbers vary from one study to the next (from five to 45 percent), an elevated risk is consistently observed.

"Awareness of the incidence of cancer-associated bone loss raises issues for clinicians who should identify those patients who are most at risk for fractures and prescribe treatment strategies," says Dr. Saad. "This information is not only a concern for the specialists, but also for the general practitioners who frequently encounter these patients."

Bisphosphonate treatment reduces bone loss

Dr. Saad's group also evaluated data that included bisphosphonate treatment for cancer patients receiving chemotherapy. Prostate cancer patients who received bisphosphonate treatment and androgen deprivation therapy did show an increase in bone loss. In the same vane, there was a protective effect on bone loss for breast cancer patients who were treated with bisphosphonates.

"It is clear that the use of bisphosphonates attenuates bone loss," concludes Dr. Saad. "However, the optimal dosing and long-term impact is unclear and needs to be determined. Other measures to combat the bone loss, such as exercise, vitamin D intake, avoidance of cigarettes, may also be beneficial


'/>"/>

Contact: Sylvain-Jacques Desjardins
sylvain-jacques.desjardins@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Related medicine news :

1. American Academy of Dermatology: Stop Skin Cancer On The Spot
2. Gender is key factor in determining overall survival of lung cancer patients
3. Proton therapy may reduce serious side effect of lung cancer treatment
4. Tissue analyses indicate survival benefits for some lung cancer patients
5. Advanced lung cancer patients see improved, progression-free survival
6. Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
7. Research demonstrates differing genetic makeup of lung cancer in African-American patients
8. Novel 4-drug combination proves safe for lung cancer treatment
9. US Oncology Applauds Senator Baucuss Healthcare Reform Call to Action for 2009, Supports Collaborative Measures to Enhance Cancer Patients Access to Care While Improving Quality and Access
10. AACR to host 7th Annual International Conference on Frontiers in Cancer Prevention Research
11. TV News Story on Canine Cancer Generates Dog Lover Response - No. 1 Health Issue for Americas 40 Million Dog-Owning Households
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... 2016 , ... Norwood Insurance Group, serving families of Dallas ... ongoing community enrichment program. The current campaign is being extended to continue fundraising ... months of treatments, leaving his family in great need of financial assistance. Donations ...
(Date:5/6/2016)... , ... May 06, 2016 , ... US Sports Camps ... rugby camp held at Oregon State University this summer. Employing world-class rugby figures, including ... of all skill levels with training on key fundamentals, match play, fitness and more. ...
(Date:5/6/2016)... ... May 06, 2016 , ... Logically, spring weather, with its moderate humidity ... is too cold, dry or hot, water on the eye surface can evaporate, creating ... the surrounding air. There’s only one problem, according to radio show and water advocate ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... The International ... Resort on the north end of the island close to the town famous for ... August 10th 2016. , “We continue to have an amazing experience in Greece, ...
(Date:5/6/2016)... ... May 06, 2016 , ... In honor ... education and corporate training, and the National Military Family Association, a nonprofit that ... as the second full-tuition scholarship recipient of 2016. , “Being awarded this ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016 In March, 2016, ... of free workshops across Africa ... for Good Distribution Practices (GDP). Good Distribution Practice ... products are consistently stored, transported and handled under suitable ... specification. Only a few years ago, there were ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Ischemic Stroke Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Ischemic Stroke Market and Competitive Landscape Highlights ... Stroke pipeline products, Acute Ischemic Stroke epidemiology, ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute lymphocytic Leukemia ...  report to their offering.       ... Global Acute Lymphocytic Leukemia Market and Competitive ... Acute Lymphocytic Leukemia pipeline products, Acute Lymphocytic ...
Breaking Medicine Technology: